Form D · Biotechnology

Apic Bio, Inc.

Cambridge, MA · CIK 0001759575

Offering snapshot reported Jul 28, 2022 · SEC filing

Reported sold
$8.35M
Offering amount: $8.35M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 17, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.18M$8.35MDec 30, 2021: $4,000,000.00Dec 30, 2021Mar 9, 2022: $4,500,000.00Mar 9, 2022Jul 28, 2022: $8,350,000.00Jul 28, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,500,000 → $8,350,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2022Amendment$8,350,000$3,850,000vs Mar 9, 20222SEC filing
Mar 9, 2022Amendment$4,500,000$500,000vs Dec 30, 20212SEC filing
Dec 30, 2021Initial$4,000,000No comparison1SEC filing
May 12, 2021Initial$4,739,760No comparison11SEC filing
Nov 12, 2020Amendment$42,317,673$12,137,673vs Dec 30, 201913SEC filing
Dec 30, 2019Amendment$30,180,000$20,180,000vs Nov 21, 201813SEC filing
Nov 21, 2018Initial$10,000,000No comparison13SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-427261

Source: Form D, filed Jul 28, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jason Dinges Director
Stephen Hoffman Director
Christian Mueller Director
Stephanie O'brien, J.D. Director
John Reilly Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
35 Cambridgepark Drive, Suite 350
Cambridge, MA, 02140-2325